MannKind sheds light on new $100m inhaled formulation partner
MannKind has spoken about Receptor Life Science, a newly-formed company which last month licensed the Technosphere inhaled delivery platform from the struggling firm.
Archives for February 4, 2016
Sandoz teams with delivery tech firm MedinCell to get under the skin of cancer
Novartis subsidiary Sandoz will commercialise small and large molecule injectables using French delivery tech firm MedinCell’s subcutaneous controlled release platform.
Mafia behind most EU pharma cargo theft: €30m worth of drugs stolen each year says expert
The Mafia is responsible for most pharmaceutical cargo thefts in Europe according to a researcher who says €30m ($33.5m) worth of drugs are stolen while in transit across the continent each year.
Selvita to open new lab in Poland
Discovery services firm Selvita plans a new laboratory in Poland citing a desired to develop the facility as its “second heart.”
Piramal to invest $10m to add ADC capacity at Coldstream lab
Piramal has announced its intention to invest $10m (€8.9m) in Coldstream Laboratories, the US sterile injectable CDMO it bought last year.
Increased scrutiny requires digging deeper into the supply chain
As threats to the pharmaceutical supply chain prevail, the industry is seeing increased regulatory scrutiny as well as more inspection requirements, says industry panel.
Dispatches from Cell Therapy Manufacturing & Gene Therapy Congress
Vendors must collaborate to develop cell therapy production automation, experts
Cell therapy development and production will not be sustainable unless there is a vendor-led shift to automated processes, said experts in Brussels yesterday.
Update - facility expansion to continue
Therapure postpones IPO citing market conditions
Therapure Biopharma has postponed its IPO citing market conditions.